Stanford researchers have invented a twist-expand mechanical bioreactor that provides an appropriate in vitro microenvironment for induced pluripotent stem cell (iPSC) derived cardiomyocytes to achieve biomimetic anisotropic alignment and form contractile cardiac tissue
Stanford researchers in the Woo Lab have designed an implantable prosthetic for patients with aortic valve dysfunction, particularly for use in valve-sparing aortic root replacement procedures.
Stanford researchers in the Woo Lab have developed a modular bioprosthetic valve that allows for customizable leaflet configurations, ranging from bi- to multi-leaflet designs.
Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.
Stanford researchers at the Woo Lab have designed and manufactured a flexible, compact laparoscopic device for knot tying during cardiac, thoracic, and ENT operations.
Stanford researchers at the Woo Lab have designed an innovative prosthetic valve to address challenges in mitral valve replacement for patients with severe mitral annular calcification (MAC).
Stanford researchers at the Woo Lab have invented a composite inclusion graft that addresses several challenges associated with the Ross procedure, such as late autograft dilation.
Stanford researchers at the Woo Lab have developed an innovative supra-hemostasis aortic graft, an advanced version of conventional aortic grafts. Current aortic grafts do not have reinforced suture area which can cause bleeding around the anastomosis line.
Stanford scientists developed a comprehensive, minimally invasive, dual-catheter pulsed field device that utilizes a rapid and simple integrated mapping/ablation strategy for the treatment of Atrial Fibrillation.
Stanford researchers in the Woo Lab have developed a novel device that allows for direct visual assessment of the aortic valve apparatus under physiologic pressure in aortic valve procedures.
Stanford researchers have developed a contrastive learning approach that can significantly reduce the amount of labeled electrocardiogram (ECG) data required for downstream healthcare tasks, such as arrhythmia identification.
Stanford researchers have developed a new transcatheter, minimally invasive neochordal device for repair of mitral regurgitation, which does not require open heart surgery nor cardiopulmonary bypass.